Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Table of Contents

May 01, 1989; Volume 249,Issue 2
  • You have access
    Trifenagrel: a chemically novel platelet aggregation inhibitor.
    S L Abrahams, R J Hazen, A G Batson and A P Phillips
    Journal of Pharmacology and Experimental Therapeutics May 1989, 249 (2) 359-365;
  • You have access
    Cyclooxygenase inhibition unmasks the full antidiuretic agonist activity of the vasopressin antagonist, SK&F 101926, in dogs.
    C R Albrightson-Winslow, N Caldwell, D P Brooks, W F Huffman, F L Stassen and L B Kinter
    Journal of Pharmacology and Experimental Therapeutics May 1989, 249 (2) 366-371;
  • You have access
    Pharmacokinetics and pharmacodynamics of atrial natriuretic peptide after bolus and infusion administration in the isolated perfused rat kidney.
    M E Brier and G B Harding
    Journal of Pharmacology and Experimental Therapeutics May 1989, 249 (2) 372-377;
  • You have access
    Plasma protein binding of flurbiprofen: enantioselectivity and influence of pathophysiological status.
    M P Knadler, D C Brater and S D Hall
    Journal of Pharmacology and Experimental Therapeutics May 1989, 249 (2) 378-385;
  • You have access
    Differential cross-tolerance to opioid agonists in morphine-tolerant pigeons responding under a schedule of food presentation.
    R M Craft, M J Picker and L A Dykstra
    Journal of Pharmacology and Experimental Therapeutics May 1989, 249 (2) 386-393;
  • You have access
    Phosphodiesterase isozyme inhibition and the potentiation by zaprinast of endothelium-derived relaxing factor and guanylate cyclase stimulating agents in vascular smooth muscle.
    A L Harris, B M Lemp, R G Bentley, M H Perrone, L T Hamel and P J Silver
    Journal of Pharmacology and Experimental Therapeutics May 1989, 249 (2) 394-400;
  • You have access
    Unsurmountable antagonism to 5-hydroxytryptamine in rat kidney results from pseudoirreversible inhibition rather than multiple receptors or allosteric receptor modulation.
    R A Bond, A G Ornstein and D E Clarke
    Journal of Pharmacology and Experimental Therapeutics May 1989, 249 (2) 401-410;
  • You have access
    In vivo metabolism of atrial natriuretic peptide: identification of plasma metabolites and enzymes responsible for their generation.
    P A Krieter, G M Olins, S P Verrett and R C Durley
    Journal of Pharmacology and Experimental Therapeutics May 1989, 249 (2) 411-417;
  • You have access
    Benzodiazepine and beta-carboline interactions with GABAA receptor-gated chloride channels in mammalian cultured spinal cord neurons.
    A K Mehta and M K Ticku
    Journal of Pharmacology and Experimental Therapeutics May 1989, 249 (2) 418-423;
  • You have access
    Cysteamine produces dose-related bidirectional immunomodulatory effects in mice.
    H U Bryant, J W Holaday and E W Bernton
    Journal of Pharmacology and Experimental Therapeutics May 1989, 249 (2) 424-429;
  • You have access
    The bronchopulmonary pharmacology of SK&F 104353 in anesthetized guinea pigs: demonstration of potent and selective antagonism of responses to peptidoleukotrienes.
    T J Torphy, J F Newton, M A Wasserman, L Vickery-Clark, R R Osborn, L S Bailey, L A Yodis, D C Underwood and D W Hay
    Journal of Pharmacology and Experimental Therapeutics May 1989, 249 (2) 430-437;
  • You have access
    Pentobarbital-like discriminative stimulus effects of N-methyl-D-aspartate antagonists.
    J Willetts and R L Balster
    Journal of Pharmacology and Experimental Therapeutics May 1989, 249 (2) 438-443;
  • You have access
    Psychoactive cannabinoids reduce gastrointestinal propulsion and motility in rodents.
    J E Shook and T F Burks
    Journal of Pharmacology and Experimental Therapeutics May 1989, 249 (2) 444-449;
  • You have access
    Effect of 1,3-bis-(2-chloroethyl)-1-nitrosourea on cholephilic dye metabolism and excretion in anesthetized rats.
    D Hoyt and R E Larson
    Journal of Pharmacology and Experimental Therapeutics May 1989, 249 (2) 450-455;
  • You have access
    Sensitivity and tolerance to ethanol-induced hypothermia in genetically selected mice.
    J C Crabbe, D J Feller and J S Dorow
    Journal of Pharmacology and Experimental Therapeutics May 1989, 249 (2) 456-461;
  • You have access
    Differential modulation by [D-Pen2, D-Pen5]enkephalin and dynorphin A-(1-17) of the inhibitory bladder motility effects of selected mu agonists in vivo.
    R J Sheldon, L Nunan and F Porreca
    Journal of Pharmacology and Experimental Therapeutics May 1989, 249 (2) 462-469;
  • You have access
    Kinins contribute to the contractile effects of rat glandular kallikrein on the isolated rat uterus.
    G G Orce, O A Carretero, G Scicli and A G Scicli
    Journal of Pharmacology and Experimental Therapeutics May 1989, 249 (2) 470-475;
  • You have access
    Stereoselective uptake of atenolol into storage granules isolated from PC12 cells.
    E E Bagwell, J G Webb, T Walle and T E Gaffney
    Journal of Pharmacology and Experimental Therapeutics May 1989, 249 (2) 476-482;
  • You have access
    Effects of acute and chronic acyclovir on canine renal function.
    A S Kimes, K Kumor, K McCullough, D Holtzclaw, D Teller, D Dobyan and D Spector
    Journal of Pharmacology and Experimental Therapeutics May 1989, 249 (2) 483-491;
  • You have access
    Effects of protein kinase inhibitor, 1-(5-isoquinolinylsulfonyl)-2-methylpiperazine, on beta-2 adrenergic receptor activation and desensitization in intact human lymphocytes.
    K K Hui and J L Yu
    Journal of Pharmacology and Experimental Therapeutics May 1989, 249 (2) 492-498;
  • You have access
    Arginine8-vasopressin reduces spinal cord blood flow after spinal subarachnoid injection in rats.
    J B Long, A Martinez-Arizala, S H Johnson and J W Holaday
    Journal of Pharmacology and Experimental Therapeutics May 1989, 249 (2) 499-506;
  • You have access
    Effect of continuous exposure to selective D1 and D2 dopaminergic agonists on rotational behavior in supersensitive mice.
    J D Winkler and B Weiss
    Journal of Pharmacology and Experimental Therapeutics May 1989, 249 (2) 507-516;
  • You have access
    Mechanistic studies of the metabolic chiral inversion of (R)-ibuprofen in humans.
    T A Baillie, W J Adams, D G Kaiser, L S Olanoff, G W Halstead, H Harpootlian and G J Van Giessen
    Journal of Pharmacology and Experimental Therapeutics May 1989, 249 (2) 517-523;
  • You have access
    Cyclic GMP: a potential mediator of neurally- and drug-induced relaxation of opossum lower esophageal sphincter.
    M Barnette, T J Torphy, M Grous, C Fine and H S Ormsbee
    Journal of Pharmacology and Experimental Therapeutics May 1989, 249 (2) 524-528;
  • You have access
    Alpha adrenoceptor agonist stimulation of oxygen consumption in rat proximal and distal nephrons.
    F A Gesek and J W Strandhoy
    Journal of Pharmacology and Experimental Therapeutics May 1989, 249 (2) 529-534;
  • You have access
    Characterization of serotonin-1B receptors negatively coupled to adenylate cyclase in OK cells, a renal epithelial cell line from the opossum.
    T J Murphy and D B Bylund
    Journal of Pharmacology and Experimental Therapeutics May 1989, 249 (2) 535-543;
  • You have access
    Novel peptidic mu opioid antagonists: pharmacologic characterization in vitro and in vivo.
    T H Kramer, J E Shook, W Kazmierski, E A Ayres, W S Wire, V J Hruby and T F Burks
    Journal of Pharmacology and Experimental Therapeutics May 1989, 249 (2) 544-551;
  • You have access
    Prophylaxis of cyanobacterial and mushroom cyclic peptide toxins.
    W H Adams, R D Stoner, D G Adams, H Read, D N Slatkin and H W Siegelman
    Journal of Pharmacology and Experimental Therapeutics May 1989, 249 (2) 552-556;
  • You have access
    Discriminative stimulus effects of mu and kappa opioids in the pigeon: analysis of the effects of full and partial mu and kappa agonists.
    M J Picker and L A Dykstra
    Journal of Pharmacology and Experimental Therapeutics May 1989, 249 (2) 557-566;
  • You have access
    Characterization of the pharmacokinetic interaction between nifedipine and ethanol in the rat.
    K M Boje and H L Fung
    Journal of Pharmacology and Experimental Therapeutics May 1989, 249 (2) 567-571;
  • You have access
    Pharmacological characterization of neural mechanisms regulating mucosal ion transport in mouse jejunum.
    R J Sheldon, M E Malarchik, D A Fox, T F Burks and F Porreca
    Journal of Pharmacology and Experimental Therapeutics May 1989, 249 (2) 572-582;
  • You have access
    Human fat cell alpha-2 adrenoceptors. I. Functional exploration and pharmacological definition with selected alpha-2 agonists and antagonists.
    J Galitzky, P Mauriege, M Berlan and M Lafontan
    Journal of Pharmacology and Experimental Therapeutics May 1989, 249 (2) 583-591;
  • You have access
    Human fat cell alpha-2 adrenoceptors. II. Comparative study of partial and full agonist binding parameters using [3H]clonidine and [3H]UK-14,304.
    J Galitzky, M Lafontan, H Paris and M Berlan
    Journal of Pharmacology and Experimental Therapeutics May 1989, 249 (2) 592-600;
  • You have access
    Pharmacokinetic modeling of the anticonvulsant action of phenobarbital in rats.
    J Dingemanse, J B van Bree and M Danhof
    Journal of Pharmacology and Experimental Therapeutics May 1989, 249 (2) 601-608;
  • You have access
    Inhibition of converting enzyme in the cerebrospinal fluid of rats after oral treatment with converting enzyme inhibitors.
    P Gohlke, H Urbach, B Schölkens and T Unger
    Journal of Pharmacology and Experimental Therapeutics May 1989, 249 (2) 609-616;
  • You have access
    Mexiletine-quinidine combination: enhanced antiarrhythmic and electrophysiologic activity in the dog.
    H J Duff
    Journal of Pharmacology and Experimental Therapeutics May 1989, 249 (2) 617-622;
  • You have access
    Activation of heart sarcoplasmic reticulum Ca++-stimulated adenosine triphosphatase by insulin.
    M P Gupta, S L Lee and N S Dhalla
    Journal of Pharmacology and Experimental Therapeutics May 1989, 249 (2) 623-630;
  • You have access
    Metabolic changes in glutathione and metallothionein in newborn rat liver.
    K R Gallant and M G Cherian
    Journal of Pharmacology and Experimental Therapeutics May 1989, 249 (2) 631-637;
  • You have access
    Influence of enzyme induction and inhibition on the oxidation of nifedipine, sparteine, mephenytoin and antipyrine in humans as assessed by a "cocktail" study design.
    J H Schellens, J H van der Wart, M Brugman and D D Breimer
    Journal of Pharmacology and Experimental Therapeutics May 1989, 249 (2) 638-645;
  • You have access
    Interaction of 8-(N,N-diethylamino)octyl 3,4,5-trimethoxybenzoate hydrochloride, ryanodine and procaine with muscarinic cholinergic M2 receptor sites in smooth muscle.
    T Hisayama, I Takayanagi, N Kumagai and H Kubo
    Journal of Pharmacology and Experimental Therapeutics May 1989, 249 (2) 646-651;
  • You have access
    Modulation of pyloric motor activity via adrenergic receptors.
    H D Allescher, S Ahmad, F Kostolanska, C Y Kwan and E E Daniel
    Journal of Pharmacology and Experimental Therapeutics May 1989, 249 (2) 652-659;
  • You have access
    Catechol and indole metabolism in rostral ventrolateral medulla change synchronously with changing blood pressure.
    D Bhaskaran and C R Freed
    Journal of Pharmacology and Experimental Therapeutics May 1989, 249 (2) 660-666;
  • You have access
    Potentiation of 3-methylcholanthrene induction of rat hepatic cytochrome P450IA1 by dexamethasone in vivo.
    A J Sherratt, D E Banet, M W Linder and R A Prough
    Journal of Pharmacology and Experimental Therapeutics May 1989, 249 (2) 667-672;
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 249, Issue 2
1 May 1989
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.
  • Functional Selectivity and Classical Concepts of Quantitative Pharmacology
  • Abl Protein-Tyrosine Kinase Inhibitor STI571 Inhibits In Vitro Signal Transduction Mediated by c-Kit and Platelet-Derived Growth Factor Receptors
  • The Prediction of Human Pharmacokinetic Parameters from Preclinical and In Vitro Metabolism Data
  • A METHOD FOR DETERMINING LOSS OF PAIN SENSATION
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics